5Goto Y,HO SL,McAdoo J,et al.General versus regional anaesthesia for cataract surgery:effects on neutrophil apoptosis and the postoperative pro-inflammatory state. European Journal of Anaesthesiology . 2008
6Smith WD,Dutton RC,Smith NT,et al.Measuring the performance of anesthetic depth indicators. Anesthesiology . 2006
7Wang GN,Weng YQ,I Shi.The effect of tramadol on serum cytokine response in patients undergoing pulmonary lobectomy. Journal of Clinical Anesthesia . 2005
8Raymond E,Faivre S,Woynarowski JM,et al.Oxaliplatin;Mechanism of action and Antineoplastic activity. Seminars in Oncology . 2008
9Inada T,Yamanouchi Y,Jomura S,et al.Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia . 2004
5Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol,1999, 163:5211-5218.
6Overwijk WW, Lee DS, Surman DR, et al. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci U S A,1999,96:2982-2987.
7Bronte V, Apolloni E, Ronca R,et al. Genetic vaccination with "self " tyrosinase-related protein 2 causes melanoma eradication but not vitiligo. Cancer Res,2000,60:253-258.
8Houghton AN, Gold JS, Blachere NE. Immunity against cancer: lessons learned from melanoma. Curr Opin Immunol,2001,13:134-140.
9Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients.Clin Cancer Res, 2003, 9:606-612.
10Onizuka S, Tawara I, Shimizu J, et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.Cancer Res, 1999, 59:3128-3133.
3Lee NK, Shin KH, Park IH, et al. Stage-to-stage comparison of neo- adjuvant chemotherapy versus adjuvant chemotherapy in pathologi- cal lymph node positive breast cancer patients [ J ]. Japanese Jour- nal of Clinical Oncology,2012,42 ( 11 ) :995 - 1001.
5Terzi6 J, Grivennikov S, Karin E, et al. Inflammation and colon canc- er [ J ]. Gastroenterology, 201 O, 138 ( 6 ) : 2101 - 2114, e5.
6West NP, Sutton K M, Ingeholm P, et al. Improving the quality of co- lon cancer surgery through a surgical education program[ J]. Dis Co- lon Rectum,2010,53 (12) : 1594 - 1603.
7West N,Morris E,Finan P,et al. Study to identify the optimum sur- gical technique in colon cancer[ J ]. Lancet, 2014,383 : S 107.
8Hung A, Mullins CD. Relative effectiveness and safety of chemother- apy in elderly and nonelderly patients with stage Ⅲ colon cancer:a systematic review[ J ]. Oncologist ,2013,18 ( 1 ) :54 - 63.
9Panis Y, Maggiori L, Caranhac G, et al. Mortality after colorectal cancer surgery : a French survey of more than 84,000 patients [ J ]. Ann surg,2011,254(5) :738 -744.
10Di Mitri D, Azevedo RI, Henson SM, et al. Reversible senescence in human CIM + CD4sRA + CD27 - memory T cells[ J]. J Immunol, 2011,187(5) :2093 -2100.
